Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pattern-recognition receptors (PRRs) in SARS-CoV-2.
Isazadeh A, Heris JA, Shahabi P, Mohammadinasab R, Shomali N, Nasiri H, Valedkarimi Z, Khosroshahi AJ, Hajazimian S, Akbari M, Sadeghvand S. Isazadeh A, et al. Among authors: akbari m. Life Sci. 2023 Sep 15;329:121940. doi: 10.1016/j.lfs.2023.121940. Epub 2023 Jul 12. Life Sci. 2023. PMID: 37451397 Review.
miR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro.
Nabipoorashrafi SA, Shomali N, Sadat-Hatamnezhad L, Mahami-Oskouei M, Mahmoudi J, Sandoghchian Shotorbani B, Akbari M, Xu H, Sandoghchian Shotorbani S. Nabipoorashrafi SA, et al. Among authors: akbari m. IUBMB Life. 2020 Sep;72(9):2034-2044. doi: 10.1002/iub.2345. Epub 2020 Jul 20. IUBMB Life. 2020. PMID: 32687246 Free article.
Innate and adaptive immune responses against coronavirus.
Hosseini A, Hashemi V, Shomali N, Asghari F, Gharibi T, Akbari M, Gholizadeh S, Jafari A. Hosseini A, et al. Among authors: akbari m. Biomed Pharmacother. 2020 Dec;132:110859. doi: 10.1016/j.biopha.2020.110859. Epub 2020 Oct 22. Biomed Pharmacother. 2020. PMID: 33120236 Free PMC article. Review.
miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
Azar MRMH, Aghazadeh H, Mohammed HN, Sara MRS, Hosseini A, Shomali N, Tamjidifar R, Tarzi S, Mansouri M, Sarand SP, Marofi F, Akbari M, Xu H, Shotorbani SS. Azar MRMH, et al. Among authors: akbari m. Int Immunopharmacol. 2021 Mar;92:107355. doi: 10.1016/j.intimp.2020.107355. Epub 2021 Jan 8. Int Immunopharmacol. 2021. PMID: 33429333
1,594 results